J L McCauley1, G H Gilbert2, D L Cochran3, V V Gordan4, R S Leite5, R B Fillingim6, K T Brady1,7. 1. 1 Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. 2. 2 Department of Clinical and Community Sciences, University of Alabama at Birmingham, Birmingham, USA. 3. 3 Department of Periodontics, UT Health San Antonio, San Antonio, USA. 4. 4 Department of Restorative Dental Sciences, University of Florida, Gainesville, FL, USA. 5. 5 Department of Stomatology, Medical University of South Carolina, Charleston, SC, USA. 6. 6 Department of Restorative Dental Sciences, University of Florida, USA. 7. 7 Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC, USA.
Abstract
INTRODUCTION: The American Dental Association recommends that dentists use a prescription drug monitoring program (PDMP) prior to prescribing an opioid for acute pain management. OBJECTIVE: The objective of this study was to examine dentists' experiences using their state PDMP, as well as the impact that state-mandated registration policies, mandated use policies, and practice characteristics had on the frequency with which dentists used their PDMP. METHODS: We conducted a web-based cross-sectional survey among practicing dentist members of the National Dental Practice-Based Research Network ( n = 805). The survey assessed prescribing practices for pain management and implementation of risk mitigation strategies, including PDMP use. Survey data were linked with network Enrollment Questionnaire data to include practitioner demographics and practice characteristics. RESULTS: Nearly half of respondents ( n = 375, 46.6%) reported having never accessed a PDMP, with the most common reasons for nonaccess being lack of awareness ( n = 214, 57.1%) and lack of knowledge regarding registration and use ( n = 94, 25.1%). The majority of PDMP users reported the program to be very helpful (58.1%) or somewhat helpful (31.6%). Dentists reported that PDMP use most often did not change their intended prescribing behavior (40.2%), led them not to prescribe an opioid (33.5%), or led them to prescribe fewer opioid doses (25.5%). Presence of a mandated use policy was significantly associated with increased frequency of PDMP use across a variety of situations, including prior to 1) prescribing any opioid for pain management, 2) issuing refills, 3) prescribing to new patients, and 4) prescribing to patients deemed high risk. CONCLUSION: Findings suggest that the majority of dentists find PDMPs helpful in informing their opioid-prescribing practices. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists' PDMP use, outreach and education efforts may overcome key barriers to use identified in this study. KNOWLEDGE TRANSFER STATEMENT: Findings from this national survey suggest that the majority of practicing dentists find PDMPs helpful in informing their opioid-prescribing practices; however, consistent PDMP use was not common. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists' PDMP use, outreach and education efforts may overcome key barriers to use identified in this study.
INTRODUCTION: The American Dental Association recommends that dentists use a prescription drug monitoring program (PDMP) prior to prescribing an opioid for acute pain management. OBJECTIVE: The objective of this study was to examine dentists' experiences using their state PDMP, as well as the impact that state-mandated registration policies, mandated use policies, and practice characteristics had on the frequency with which dentists used their PDMP. METHODS: We conducted a web-based cross-sectional survey among practicing dentist members of the National Dental Practice-Based Research Network ( n = 805). The survey assessed prescribing practices for pain management and implementation of risk mitigation strategies, including PDMP use. Survey data were linked with network Enrollment Questionnaire data to include practitioner demographics and practice characteristics. RESULTS: Nearly half of respondents ( n = 375, 46.6%) reported having never accessed a PDMP, with the most common reasons for nonaccess being lack of awareness ( n = 214, 57.1%) and lack of knowledge regarding registration and use ( n = 94, 25.1%). The majority of PDMP users reported the program to be very helpful (58.1%) or somewhat helpful (31.6%). Dentists reported that PDMP use most often did not change their intended prescribing behavior (40.2%), led them not to prescribe an opioid (33.5%), or led them to prescribe fewer opioid doses (25.5%). Presence of a mandated use policy was significantly associated with increased frequency of PDMP use across a variety of situations, including prior to 1) prescribing any opioid for pain management, 2) issuing refills, 3) prescribing to new patients, and 4) prescribing to patients deemed high risk. CONCLUSION: Findings suggest that the majority of dentists find PDMPs helpful in informing their opioid-prescribing practices. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists' PDMP use, outreach and education efforts may overcome key barriers to use identified in this study. KNOWLEDGE TRANSFER STATEMENT: Findings from this national survey suggest that the majority of practicing dentists find PDMPs helpful in informing their opioid-prescribing practices; however, consistent PDMP use was not common. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists' PDMP use, outreach and education efforts may overcome key barriers to use identified in this study.
Entities:
Keywords:
behavior and behavior mechanisms; dentistry; education; prescription drug abuse; substance abuse; substance-related disorders
Authors: Tim J Heaven; Valeria V Gordan; Mark S Litaker; Jeffrey L Fellows; D Brad Rindal; Gregg H Gilbert Journal: J Dent Date: 2015-05-18 Impact factor: 4.379
Authors: Richard Radnovich; C Richard Chapman; Jeffrey A Gudin; Sunil J Panchal; Lynn R Webster; Joseph V Pergolizzi Journal: Postgrad Med Date: 2014-07 Impact factor: 3.840
Authors: Liza M Reifler; Danna Droz; J Elise Bailey; Sidney H Schnoll; Reginald Fant; Richard C Dart; Becki Bucher Bartelson Journal: Pain Med Date: 2012-02-02 Impact factor: 3.750
Authors: Gregg H Gilbert; Joshua S Richman; Valeria V Gordan; D Brad Rindal; Jeffrey L Fellows; Paul L Benjamin; Martha Wallace-Dawson; O Dale Williams Journal: J Dent Educ Date: 2011-04 Impact factor: 2.264
Authors: Jenna L McCauley; Renata S Leite; Valeria V Gordan; Roger B Fillingim; Gregg H Gilbert; Cyril Meyerowitz; David Cochran; D Brad Rindal; Kathleen T Brady Journal: J Am Dent Assoc Date: 2018-03-15 Impact factor: 3.634
Authors: Richard A Deyo; Sara E Hallvik; Christi Hildebran; Miguel Marino; Rachel Springer; Jessica M Irvine; Nicole O'Kane; Joshua Van Otterloo; Dagan A Wright; Gillian Leichtling; Lisa M Millet; Jody Carson; Wayne Wakeland; Dennis McCarty Journal: J Pain Date: 2017-10-18 Impact factor: 5.820
Authors: Gregg H Gilbert; Valeria V Gordan; James J Korelitz; Jeffrey L Fellows; Cyril Meyerowitz; Thomas W Oates; D Brad Rindal; Randall J Gregory Journal: BMC Oral Health Date: 2015-01-22 Impact factor: 2.757
Authors: Jean-Luc C Mougeot; James M Davis; Jing Zhao; Kathleen A Sullivan; Martin H Thornhill; Patrick E McKnight; Casey Stephens; Peter B Lockhart Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2020-06-12
Authors: Steven J Scrivani; David A Keith; Ronald J Kulich; Alexandre F DaSilva; R Bruce Donoff; Shruti Handa; Nicole Holland; Mark A Lerman; Jenna L McCauley; Lori Reisner; Cory M Resnick; Christian S Stohler; Alexis Vasciannie; Matthew Fortino; Michael E Schatman Journal: J Pain Res Date: 2021-05-24 Impact factor: 3.133